Med Spa Valuation in 2026: What Your Practice Is Worth Now
If you own a med spa in 2026, you are operating in one of the most actively bought sectors in healthcare. The medical aesthetics market has passed 17 billion dollars and is growing by more than a billion dollars a year, yet roughly 81 percent of med spas are still single-location practices and only about 8 percent belong to a franchise, private-equity group, or national chain. That gap between a large, growing market and a fragmented owner base is exactly what is drawing capital in. The question most owners are now asking is simple: what is my med spa actually worth, and is this the moment to find out?
This guide walks through how med spas are valued today, the multiples buyers are paying, the drivers that move your number up or down, and the structures private equity is using in 2026. Vallexa Advisors works on the sell side for med spa and medical aesthetics owners, so the goal here is practical: give you a clear, honest picture of value before you make any decision. A med spa valuation is the first step, and it commits you to nothing.
How much is a med spa worth in 2026?
As of June 2026, most med spas trade between 4.0x and 7.0x EBITDA for single-location practices and add-on acquisitions, and between 7.0x and 9.0x EBITDA for multi-location operations. Larger, well-branded platforms with proven profitability and a broad customer base can reach 7.0x to 12.0x. Very small owner-operated practices are often valued on Seller’s Discretionary Earnings (SDE) instead, which produces a lower headline multiple because so much of the profit depends on the owner. These are ranges, not promises. Where your practice lands depends on size, service mix, provider retention, recurring revenue, and how clean your compliance structure is.
| Med spa profile | Typical 2026 multiple | What buyers reward |
|---|---|---|
| Single owner-operated site (small) | 3.0x to 4.5x SDE | Clean books, transferable provider relationships |
| Single location (established) | 4.0x to 7.0x EBITDA | Recurring memberships, injectables mix, margin |
| Multi-location (3 or more sites) | 7.0x to 9.0x EBITDA | Standardized SOPs, central admin, provider depth |
| Branded regional platform | up to 12.0x EBITDA | Scale, brand equity, growth, payer-independent revenue |
What multiple does a med spa sell for?
A med spa sells for a multiple of its adjusted EBITDA, and the size of that multiple is mostly a measure of how transferable and predictable the earnings are. Private equity buyers, who now drive most of the larger transactions, typically value practices on trailing-twelve-month adjusted EBITDA in a 5.0x to 12.0x range, with the number rising for scale, growth, and provider depth. The single biggest swing factor is whether the business depends on you. If you are the top injector and the brand, a buyer treats much of that revenue as a key-person risk and prices it accordingly.
Add-backs matter here too. An add-back is an expense a buyer agrees they will not inherit, such as an above-market owner salary or a one-time buildout cost. In 2026, buyers are disciplined about which ones they accept. The most scrutinized add-back in a med spa deal is the owner’s clinical compensation. If you personally generate a large share of injectable revenue, a buyer will not simply add your salary back to profit. They will ask who treats those patients after you step back, and they will hold part of the price in an earnout tied to the answer.
What drives a med spa’s valuation multiple?
The multiple a buyer applies reflects risk. The more your revenue repeats on its own, and the less it depends on any single person, the higher the number. As of June 2026, these are the levers that move it most.
| Driver | Effect on multiple | Why buyers care |
|---|---|---|
| Recurring membership revenue | Raises | Predictable cash flow that survives a transition |
| Injectables as a large share of revenue | Raises | High-margin, repeat treatments every few months |
| Provider depth beyond the owner | Raises | Earnings stay when the owner steps back |
| Clean MSO or PC compliance structure | Raises | Removes legal risk under corporate practice rules |
| Owner is the primary injector | Lowers | Revenue may leave with the owner |
| Heavy reliance on one device or one vendor | Lowers | Concentration and capital-replacement risk |
Buyers do not pay for potential. They pay for proof: a membership base that renews, a treatment calendar that fills without you, and a provider team that patients trust. Most of these levers can be improved in the 6 to 12 months before a sale, which is why an early valuation is worth far more than a last-minute one.
How do memberships and injectables change med spa value?
Recurring revenue is the heart of a premium med spa valuation. Memberships, prepaid packages, and standing injectable appointments turn one-time visits into predictable income, and buyers pay a higher multiple for income they can forecast. A practice where 40 percent of revenue is contracted or repeats on a known schedule is worth more, per dollar of profit, than a practice of the same size that starts every month at zero.
Service mix shapes the number as well. Neurotoxins and dermal fillers are high-margin and naturally repeat, since patients return every three to four months, so a strong injectables base supports a higher multiple. Device-heavy revenue, such as lasers and body contouring, carries capital-replacement risk that buyers discount. Fast-growing categories like medical weight loss can add value, but buyers will test how exposed you are to a single drug, supplier, or pricing change before they pay up for it.
How does the corporate practice of medicine affect a med spa sale?
In many states, the corporate practice of medicine doctrine requires that a medical practice be owned by a licensed physician, which is why most med spas operate through a management services organization paired with a professional corporation, known as an MSO or PC structure. For a buyer, this is not a technicality. It is one of the first things diligence examines, because a non-compliant ownership or fee structure can unwind a deal or create liability that follows the new owner.
A clean, well-documented MSO structure raises your value because it removes legal uncertainty and makes the business straightforward to acquire. A structure that was improvised as the practice grew tends to surface late in diligence, where it costs time, price, or the deal itself. If you expect to sell within a few years, having counsel confirm your structure early is one of the highest-return things you can do, and it is a core part of how an advisor prepares a med spa for market.
See where your med spa stands. Run a confidential estimate with the free valuation calculator, then request a no-obligation valuation from Vallexa Advisors to test the number against live buyer demand.
How do I calculate my med spa’s value?
You estimate a med spa’s value by normalizing earnings, applying a market multiple for your size and profile, and then adjusting for the risks a buyer will test in diligence. Here is the sequence an M&A advisor works through.
- Start with trailing-twelve-month revenue and net income from your current financials, not last year’s tax return.
- Rebuild EBITDA by adding back interest, taxes, depreciation, and amortization to net income.
- Apply defensible add-backs only, such as above-market owner pay and true one-time costs, and be honest about the share of revenue you personally produce as an injector.
- Select your segment multiple, for example 4.0x to 7.0x EBITDA for an established single location.
- Adjust for recurring revenue, crediting memberships and repeat injectables and discounting one-time, device-driven sales.
- Adjust for provider concentration, discounting if you are the primary injector and crediting a deep, retained team.
- Confirm your compliance structure, since a clean MSO or PC arrangement supports the top of the range and a questionable one caps it.
- Validate against live demand, because a calculator gives a range while an advisor with active buyers tells you what the market will actually pay.
Should I sell my med spa now or wait?
Get a valuation now, even if you are years from selling. A valuation is a diagnostic, not a commitment, and it shows you which levers are costing you multiple turns while you still have time to fix them. The timing also matters more than usual in 2026. Several large private-equity-backed platforms, including groups such as Empower Aesthetics, Alpha Aesthetics, Advanced MedAesthetic Partners, and Well Labs Plus, are moving through their recapitalization cycles, and that activity tends to pull buyer demand and add-on appetite up across the sector.
Publicly announced med spa deals grew from a handful in 2019 to more than 50 a year in 2023 and 2024, and 2026 is expected to be one of the strongest years yet. A market this active rewards owners who are prepared and ready to move when a strong buyer appears. Knowing your number today lets you decide from a position of information rather than urgency, whether that means selling into current demand or spending a year making your practice worth more first.
What do private equity buyers look for in a med spa in 2026?
Private equity buyers look for a practice that runs as a business, not as an extension of the founder. They want standardized operating procedures, a provider team that can grow without the owner in every room, recurring revenue, and a compliant structure. Scale helps, which is why platforms prefer three or more sites with consistent systems, but a single strong location with clean operations is a sought-after add-on.
Deal structure is where med spa transactions differ from a simple cash sale. Most 2025 and 2026 deals were structured as roughly 60 percent cash at close with 40 percent rollover equity, and some ran up to 80 percent cash with 20 percent rollover. Holdbacks and earnouts are commonly tied directly to provider retention, since buyers are protecting against the risk that key injectors leave. A growing share of 2026 activity also takes the form of minority recapitalizations, where private equity takes a minority position and the owner keeps control while taking some money off the table. That structure can be attractive if you believe in the next stage of growth and want a partner rather than an exit.
How can I increase my med spa’s value before a sale?
You increase value by improving the drivers that move the multiple in the 6 to 12 months before you go to market. A single turn of multiple on a practice with 1 million dollars of EBITDA is 1 million dollars of enterprise value, so the preparation window is where most of the money is made or lost.
- Build recurring revenue. Grow memberships and prepaid packages so a larger share of income repeats on a known schedule.
- Reduce your clinical dependence. Hire and retain injectors, shift patients onto the practice rather than onto you, and document the relationships.
- Protect your provider team. Retention agreements and a healthy culture lower the transition risk buyers price into the multiple.
- Confirm your compliance structure. Have counsel verify your MSO or PC arrangement and fee flows before diligence, not during it.
- Clean up the financials. Reconcile monthly, separate personal expenses, and keep add-backs defensible so your adjusted EBITDA survives scrutiny.
This is the difference between a valuation that confirms today’s number and one that shows you a higher number you can still reach. An advisor who sees these patterns across many transactions can tell you which one or two levers will move your multiple the most, so you spend the preparation year on what pays.
Frequently asked questions about med spa valuation
What multiple do med spas sell for in 2026?
Most med spas sell for 4.0x to 7.0x EBITDA as single locations and 7.0x to 9.0x EBITDA as multi-location operations, with branded platforms reaching up to 12.0x. The exact multiple depends on recurring revenue, provider depth, service mix, and how clean the compliance structure is.
Is owning a med spa profitable?
Well-run med spas can be highly profitable, particularly those weighted toward high-margin injectables and recurring memberships. Profitability is also what underpins enterprise value, since buyers pay a multiple of sustainable, adjusted EBITDA rather than of revenue alone.
Do I need a medical director to sell my med spa?
In most states a med spa must operate under a compliant ownership and medical-oversight structure, commonly an MSO paired with a physician-owned professional corporation. A clean structure is one of the first things a buyer verifies, so confirm how the rules apply to you with qualified counsel before going to market.
How does rollover equity work in a med spa sale?
Rollover equity is the portion of the price you reinvest in the buyer’s company rather than taking in cash. Many 2026 med spa deals are structured as roughly 60 percent cash and 40 percent rollover, which lets you take money off the table now while keeping a stake in the larger platform’s future growth.
What is a minority recapitalization?
A minority recapitalization is a deal in which an investor takes a minority stake and the owner keeps control. It is increasingly common in 2026 med spa transactions because it lets owners take some money off the table and gain a growth partner without giving up day-to-day control.
How long does it take to sell a med spa?
A well-prepared, confidential process typically runs 6 to 9 months from valuation to close, depending on the practice’s size, the cleanliness of its books and compliance structure, and the depth of buyer interest. Starting with a valuation 6 to 12 months earlier gives you time to raise the drivers that lift your multiple.
Will a valuation obligate me to sell?
No. A valuation is confidential and carries no obligation. It is a planning tool that tells you what your med spa is worth today and what would make it worth more, so any future decision is yours to make on your own timeline.
About the author
Jason Atty is the founder of Vallexa Advisors, a healthcare and medical aesthetics M&A advisory firm that advises med spa, home health, hospice, and home care owners on the sale of their businesses. Vallexa works on a success-based fee, runs a confidentiality-first process behind NDA-gated buyer disclosure, and maintains a nationwide buyer network. The firm helps owners understand value, prepare intelligently, and run a confidential sale process that attracts qualified buyers.
Find out what your med spa is worth. Start with the free valuation calculator, then book a confidential conversation with Vallexa Advisors. If you are mapping the full process first, review the 7 steps to selling.
Educational only. Not legal, financial, or tax advice. Medical aesthetics M&A outcomes depend on specific facts, service mix, state regulation, and market conditions. Speak with qualified counsel before acting on anything in this document.
Key Takeaways
- Med spa valuation in 2026 reflects significant market growth, with valuations ranging from 3.0x to 12.0x EBITDA based on size and profitability.
- Key drivers for med spa valuation include recurring revenue, provider depth, and compliance structures that minimize risk.
- Buyers prioritize practices with predictable income and well-documented management structures, impacting how much they pay.
- It’s crucial to have a valuation now to understand your med spa’s worth and improve its value before a potential sale.
- Private equity buyers want practices that operate independently of the owner, with a focus on standardized procedures and recurring revenue.
Estimated reading time: 12 minutes
